or Try an Advanced Search...

    Technical Analysis for NEXI - NexImmune, Inc.

    Grade Last Price % Change Price Change
    F 0.22 -40.24% -0.15
    NEXI closed down 40.24 percent on Friday, November 1, 2024, on 82 percent of normal volume.
    Earnings due: Nov 15
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NEXI trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 20 DMA Bullish -40.24%
    Wide Range Bar Range Expansion -40.24%
    Wide Bands Range Expansion -40.24%
    Above Upper BB Strength -40.24%
    Gapped Up Strength -40.24%
    Upper Bollinger Band Touch Strength -40.24%
    Older End-of-Day Signals for NEXI ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 21 hours ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 3% 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NEXI Chart by TradingView
    Basic chart:

    Profile

    NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

    Is NEXI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 28.6949
    52 Week Low 0.2
    Average Volume 3,252
    200-Day Moving Average 3.69
    50-Day Moving Average 0.43
    20-Day Moving Average 0.25
    10-Day Moving Average 0.26
    Average True Range 0.09
    RSI (14) 43.18
    ADX 21.64
    +DI 34.57
    -DI 14.66
    Chandelier Exit (Long, 3 ATRs) 0.14
    Chandelier Exit (Short, 3 ATRs) 0.48
    Upper Bollinger Bands 0.32
    Lower Bollinger Band 0.17
    Percent B (%b) 0.35
    BandWidth 64.90
    MACD Line -0.05
    MACD Signal Line -0.08
    MACD Histogram 0.0258
    Fundamentals Value
    Market Cap 287.99 Thousand
    Num Shares 1.3 Million
    EPS -42.05
    Price-to-Earnings (P/E) Ratio -0.01
    Price-to-Sales 0.00
    Price-to-Book 1.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.45
    Resistance 3 (R3) 0.47 0.42 0.41
    Resistance 2 (R2) 0.42 0.36 0.41 0.40
    Resistance 1 (R1) 0.32 0.33 0.30 0.30 0.38
    Pivot Point 0.27 0.27 0.26 0.26 0.27
    Support 1 (S1) 0.17 0.21 0.15 0.15 0.06
    Support 2 (S2) 0.12 0.18 0.11 0.05
    Support 3 (S3) 0.02 0.12 0.03
    Support 4 (S4) 0.00